Literature DB >> 6546328

Chlamydia trachomatis urethral infections in men. Prevalence, risk factors, and clinical manifestations.

W E Stamm, L A Koutsky, J K Benedetti, J L Jourden, R C Brunham, K K Holmes.   

Abstract

Twelve percent of 596 men presenting to a sexually transmitted disease clinic had positive urethral cultures for Chlamydia trachomatis, and 53% had microimmunofluorescent antibody to chlamydia. Prevalence of C. trachomatis urethral infection was greater in heterosexual than homosexual men (14% versus 5%; p less than 0.01), in men under 20 years of age, and in blacks. Only 10% of men with gonococcal urethral infection lacked symptoms or signs of urethritis, whereas nearly 25% of men with C. trachomatis urethral infection had no signs and symptoms, 33% lacked abnormal numbers of leukocytes on urethral Gram stain, and 50% were identified and treated solely on the basis of a screening culture. The number of newly diagnosed cases found by screening cultures was 1.3 per 100 cultures for gonorrhea but 5.5 per 100 for chlamydial infection. Clinicians appropriately treated 91% of men with gonococcal urethritis on their initial visit before culture results were available versus only 51% of men with chlamydial urethral infection. Asymptomatic urethral infections in men eventually contribute to chlamydial infections in women, and culture screening for their detection appears warranted in high-risk populations.

Entities:  

Mesh:

Year:  1984        PMID: 6546328     DOI: 10.7326/0003-4819-100-1-47

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  38 in total

1.  Prevalence of Chlamydia trachomatis in young men in north west London.

Authors:  T Pierpoint; B Thomas; A Judd; R Brugha; D Taylor-Robinson; A Renton
Journal:  Sex Transm Infect       Date:  2000-08       Impact factor: 3.519

2.  Simplification of procedures used to test urine samples for Chlamydia trachomatis.

Authors:  B J Thomas; C Gilchrist; P E Hay; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1991-05       Impact factor: 3.411

3.  Screening for Chlamydia trachomatis in adolescent males: a cost-based decision analysis.

Authors:  A G Randolph; A E Washington
Journal:  Am J Public Health       Date:  1990-05       Impact factor: 9.308

4.  Detection of Chlamydia trachomatis by the polymerase chain reaction in swabs and urine from men with non-gonococcal urethritis.

Authors:  H M Palmer; C B Gilroy; B J Thomas; P E Hay; C Gilchrist; D Taylor-Robinson
Journal:  J Clin Pathol       Date:  1991-04       Impact factor: 3.411

5.  Genital chlamydial infection among women in Nicaragua: validity of direct fluorescent antibody testing, prevalence, risk factors and clinical manifestations.

Authors:  B Herrmann; F Espinoza; R R Villegas; G D Smith; A Ramos; M Egger
Journal:  Genitourin Med       Date:  1996-02

6.  Detection by broad-range real-time PCR assay of Chlamydia species infecting human and animals.

Authors:  P Goldschmidt; H Rostane; M Sow; A Goépogui; L Batellier; C Chaumeil
Journal:  Br J Ophthalmol       Date:  2006-08-09       Impact factor: 4.638

7.  Prevalence of chlamydia and gonorrhoea among a population of men who have sex with men.

Authors:  R L Cook; K St George; A J Silvestre; S A Riddler; M Lassak; C R Rinaldo
Journal:  Sex Transm Infect       Date:  2002-06       Impact factor: 3.519

8.  Comparison of performances of two commercially available tests, a PCR assay and a ligase chain reaction test, in detection of urogenital Chlamydia trachomatis infection.

Authors:  M Puolakkainen; E Hiltunen-Back; T Reunala; S Suhonen; P Lähteenmäki; M Lehtinen; J Paavonen
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

9.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

10.  Predictors of chlamydial infection and gonorrhea among patients seen by private practitioners.

Authors:  J Vincelette; J G Baril; R Allard
Journal:  CMAJ       Date:  1991-03-15       Impact factor: 8.262

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.